CATALYST CAPITAL ADVISORS LLC Gilead Sciences, Inc. Transaction History

CATALYST CAPITAL ADVISORS LLC portfolio value:

$62,000
portfolio value

CATALYST CAPITAL ADVISORS LLC quarter portfolio value change:

-0.19%
quarter

Gilead Sciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -0.10% -1 shares 0 $61.69 1K
Q2 2022 share Decrease -71.52% -2.51K shares -147K $61.81 1.00K
Q1 2022 share Decrease -10.31% -404 shares -75K $59.45 3.51K
Q4 2021 share Decrease -1.48% -59 shares 6K $73.36 3.91K
Q3 2021 share Decrease -0.45% -18 shares 3K $69.85 3.97K
Q2 2021 share Increase +437.10% 3.25K shares 227K $68.17 3.99K
Q1 2021 share Decrease -15.74% -139 shares -3K $63.33 744
Q4 2020 share Decrease -70.57% -2.11K shares -139K $56.43 883
Q3 2020 share Decrease -33.33% -1.5K shares -156K $60.52 3K
Q2 2020 share Decrease -67.63% -9.4K shares -693K $72.94 4.5K
Q1 2020 share Increase 0.00% 13.9K shares 1.03M $70.22 13.9K
Q2 2018 share Decrease -100.00% -50.51K shares -3.80M $62.43 0
Q1 2018 share Increase +6.68% 3.16K shares 416K $65.91 50.51K
Q4 2017 share Decrease -2.68% -1.30K shares -550K $62.19 47.34K
Q3 2017 share Decrease -14.20% -8.05K shares -72K $69.84 48.65K
Q2 2017 share Increase +6.45% 3.43K shares 396K $60.63 56.70K
Q1 2017 share Increase +10.59% 5.10K shares 169K $57.72 53.27K
Q4 2016 share Increase +2.73% 1.28K shares -261K $60.39 48.16K
Q3 2016 share Decrease -0.38% -177 shares -216K $66.31 46.88K
Q2 2016 share Decrease -66.99% -95.50K shares -9.17M $69.49 47.06K
Q1 2016 share Decrease -4.62% -6.9K shares -2.02M $76.1 142.56K